Treatment of the Primary Tumor: Role of Organ-Preserving Surgery in Penile Cancer

  • Arie Stewart Parnham
  • Gideon Adam Blecher
  • Suks MinhasEmail author
Living reference work entry


Historically radical surgery has been the mainstay of penile cancer management, with the ability to pass urine being the predominant concern in terms of functional outcomes. As evidence has evolved, surgeons have had a greater confidence to take smaller margins in the knowledge that the oncological safety of the procedure is not compromised. Coupled with a more thorough appreciation of the psychological effects of diagnosis and treatment, this has led to a change in the surgical paradigm to include functional and cosmetic aspects. The use of new technologies and plastic surgical techniques has seen the use of organ-preserving surgery become the mainstay of penile cancer management.


  1. Agrawal A, et al. The histological extent of the local spread of carcinoma of the penis and its therapeutic implications. BJU Int. 2000;85(3):299–301.PubMedCrossRefGoogle Scholar
  2. Austoni E, et al. New trends in the surgical treatment of penile carcinoma. Arch Ital Urol Androl. 1996;68(3):163–8.PubMedGoogle Scholar
  3. Ayres BE, Lam W, Al-Najjar HM, Corbishley CM, Perry MJA, Watkin NA. Glans resurfacing- a new penile preserving option for superficially invasive penile cancer. Eur Urol Suppl. 2011;10(2):340.CrossRefGoogle Scholar
  4. Bandieramonte G, et al. Peniscopically controlled CO2 laser excision for conservative treatment of in situ and T1 penile carcinoma: report on 224 patients. Eur Urol. 2008;54(4):875–82.PubMedCrossRefGoogle Scholar
  5. Banon PVJ TN, Nadal VP, Pastor SG, Hernández GJA, Mas GA, Gomez GG, Gonzalez PA, Barba ME, Albacete PM. Squamous carcinoma of the penis. Arch Esp Urol. 2000;53(8):693–9.Google Scholar
  6. Bracka A. Organerhaltende operationstechnik bei karzinomen der glans penis. Akt Urol. 1996;27:1–V1.CrossRefGoogle Scholar
  7. Bracka A. Glans resection and plastic repair. BJU Int. 2010;105(1):136–44.PubMedCrossRefGoogle Scholar
  8. Brown MD, et al. Penile tumors: their management by Mohs micrographic surgery. J Dermatol Surg Oncol. 1987;13(11):1163–7.PubMedCrossRefGoogle Scholar
  9. Brown CT, Minhas S, Ralph DJ. Conservative surgery for penile cancer: subtotal glans excision without grafting. BJU Int. 2005;96(6):911–2.PubMedCrossRefGoogle Scholar
  10. Chen MF, et al. Contemporary management of penile cancer including surgery and adjuvant radiotherapy: an experience in Taiwan. World J Urol. 2004;22(1):60–6.CrossRefGoogle Scholar
  11. D’Ancona CA, et al. Quality of life after partial penectomy for penile carcinoma. Urology. 1997;50(4):593–6.PubMedCrossRefGoogle Scholar
  12. Depasquale I, Park AJ, Bracka A. The treatment of balanitis xerotica obliterans. BJU Int. 2000;86(4):459–65.PubMedCrossRefGoogle Scholar
  13. Djajadiningrat RS, et al. Penile sparing surgery for penile cancer-does it affect survival? J Urol. 2014;192(1):120–5.CrossRefGoogle Scholar
  14. Du E, et al. Refining the utility and role of frozen section in head and neck squamous cell carcinoma resection. Laryngoscope. 2016;126(8):1768–75.PubMedCrossRefGoogle Scholar
  15. Ferreiro JA, Myers JL, Bostwick DG. Accuracy of frozen section diagnosis in surgical pathology: review of a 1-year experience with 24,880 cases at Mayo Clinic Rochester. Mayo Clin Proc. 1995;70(12):1137–41.PubMedCrossRefGoogle Scholar
  16. Ficarra V, et al. General state of health and psychological well-being in patients after surgery for urological malignant neoplasms. Urol Int. 2000;65(3):130–4.PubMedCrossRefGoogle Scholar
  17. Ficarra V, et al. Local treatment of penile squamous cell carcinoma. Urol Int. 2002;69(3):169–73.PubMedCrossRefGoogle Scholar
  18. Gulino G, et al. Distal urethral reconstruction of the glans for penile carcinoma: results of a novel technique at 1-year of follow up. J Urol. 2007;178(3 Pt 1):941–4.PubMedCrossRefGoogle Scholar
  19. Hadway P, Corbishley CM, Watkin NA. Total glans resurfacing for premalignant lesions of the penis: initial outcome data. BJU Int. 2006;98(3):532–6.PubMedCrossRefGoogle Scholar
  20. Hakenberg OW, et al. EAU guidelines on penile cancer: 2014 update. Eur Urol. 2015;67(1):142–50.CrossRefGoogle Scholar
  21. Hegarty PK. A tie-over dressing for graft application in distal penectomy and glans resurfacing: the todga technique. BJU Int. 2011;107(5):840–1.PubMedCrossRefGoogle Scholar
  22. Hoffman MA, Renshaw AA, Loughlin KR. Squamous cell carcinoma of the penis and microscopic pathologic margins: how much margin is needed for local cure? Cancer. 1999;85(7):1565–8.PubMedCrossRefGoogle Scholar
  23. Hofstetter A, et al. Local irradiation by laser of a penile carcinoma. Fortschr Med. 1978;96(8):369–71.PubMedGoogle Scholar
  24. Horenblas S, van Tinteren H. Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system. J Urol. 1994;151(5):1239–43.PubMedCrossRefGoogle Scholar
  25. Korets R, et al. Partial penectomy for patients with squamous cell carcinoma of the penis: the memorial Sloan-Kettering experience. Ann Surg Oncol. 2007;14(12):3614–9.PubMedCrossRefGoogle Scholar
  26. Leijte JA, et al. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol. 2008;54(1):161–8.PubMedCrossRefGoogle Scholar
  27. Maddineni SB, Lau MM, Sangar VK. Identifying the needs of penile cancer sufferers: a systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer. BMC Urol. 2009;9:8.PubMedPubMedCentralCrossRefGoogle Scholar
  28. Meijer RP, et al. Long-term follow-up after laser therapy for penile carcinoma. Urology. 2007;69(4):759–62.PubMedCrossRefGoogle Scholar
  29. Minhas S, et al. What surgical resection margins are required to achieve oncological control in men with primary penile cancer? BJU Int. 2005;96(7):1040–3.PubMedCrossRefGoogle Scholar
  30. Mohs FE. Origins and progress of Mohs micrographic surgery. In: Mikhail GR, editor. Mohs micrographic surgery. Philadelphia: WB Saunders Co; 1991. p. 1–10.Google Scholar
  31. Mohs FE, et al. Microscopically controlled surgery in the treatment of carcinoma of the penis. J Urol. 1985;133(6):961–6.PubMedCrossRefGoogle Scholar
  32. Morelli G, et al. Glansectomy with split-thickness skin graft for the treatment of penile carcinoma. Int J Impot Res. 2009;21(5):311–4.PubMedCrossRefGoogle Scholar
  33. O'Kane HF, et al. Outcome of glansectomy and skin grafting in the management of penile cancer. Adv Urol. 2011;2011:240824.PubMedPubMedCentralCrossRefGoogle Scholar
  34. Opjordsmoen S, Fossa SD. Quality of life in patients treated for penile cancer. A follow-up study. Br J Urol. 1994;74(5):652–7.PubMedCrossRefGoogle Scholar
  35. Ornellas AA, et al. Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience. J Surg Oncol. 2008;97(6):487–95.PubMedCrossRefGoogle Scholar
  36. Palminteri E, et al. Resurfacing and reconstruction of the glans penis. Eur Urol. 2007;52(3):893–8.PubMedCrossRefGoogle Scholar
  37. Parnham AS, et al.. Glansectomy and split-thickness skin graft for penile cancer. Eur Urol. 2018;73(2):284–289.PubMedCrossRefGoogle Scholar
  38. Philippou P, et al. Conservative surgery for squamous cell carcinoma of the penis: resection margins and long-term oncological control. J Urol. 2012;188(3):803–8.PubMedCrossRefGoogle Scholar
  39. Pietrzak P, Corbishley C, Watkin N. Organ-sparing surgery for invasive penile cancer: early follow-up data. BJU Int. 2004;94(9):1253–7.CrossRefGoogle Scholar
  40. Pisani E, et al. Erectile function and ablative surgery of penile tumors. Arch Ital Urol Androl. 1994;66(1):33–4.PubMedGoogle Scholar
  41. Rempelakos A, et al. Carcinoma of the penis: experience from 360 cases. J BUON. 2004;9(1):51–5.PubMedGoogle Scholar
  42. Romero FR, et al. Sexual function after partial penectomy for penile cancer. Urology. 2005;66(6):1292–5.PubMedCrossRefGoogle Scholar
  43. Sahdev V,ZM, Stroman L, Kranz J, Muneer A, Malone P. Small but perfectly formed: urethral centralisation after partial penectomy (UCAPP). J Urol. 2016;195(4s):e639–40.CrossRefGoogle Scholar
  44. Schlenker B, et al. Fluorescence-guided laser therapy for penile carcinoma and precancerous lesions: long-term follow-up. Urol Oncol. 2011;29(6):788–93.PubMedCrossRefGoogle Scholar
  45. Shabbir M, et al. Glans resurfacing for the treatment of carcinoma in situ of the penis: surgical technique and outcomes. Eur Urol. 2011;59(1):142–7.PubMedCrossRefGoogle Scholar
  46. Shindel AW, et al. Mohs micrographic surgery for penile cancer: management and long-term follow up. J Urol. 2007;178(5):1980–5.PubMedCrossRefGoogle Scholar
  47. Skeppner E, et al. Treatment-seeking, aspects of sexual activity and life satisfaction in men with laser-treated penile carcinoma. Eur Urol. 2008;54(3):631–9.PubMedCrossRefGoogle Scholar
  48. Smith Y, et al. Reconstructive surgery for invasive squamous carcinoma of the glans penis. Eur Urol. 2007a;52(4):1179–85.PubMedCrossRefGoogle Scholar
  49. Smith Y, et al. Penile-preserving surgery for male distal urethral carcinoma. BJU Int. 2007b;100(1):82–7.PubMedCrossRefGoogle Scholar
  50. Tewari M, Kumar M, Shukla HS. Nd:YAG laser treatment of early stage carcinoma of the penis preserves form and function of penis. Asian J Surg. 2007;30(2):126–30.PubMedCrossRefGoogle Scholar
  51. Tromovitch TA, Stegman SJ. Microscopie-controlled excision of cutaneous tumors: chemosurgery, fresh tissue technique. Cancer. 1978;41(2):653–8.PubMedCrossRefGoogle Scholar
  52. Veeratterapillay R, et al. Oncologic outcomes of penile cancer treatment at a UK Supraregional Center. Urology. 2015;85(5):1097–101.PubMedCrossRefGoogle Scholar
  53. Windahl T, Andersson SO. Combined laser treatment for penile carcinoma: results after long-term follow up. J Urol. 2003;169(6):2118–21.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Arie Stewart Parnham
    • 1
  • Gideon Adam Blecher
    • 2
  • Suks Minhas
    • 3
    Email author
  1. 1.The Christie NHS Foundation TrustManchesterUK
  2. 2.University College London Hospitals NHS Foundation TrustLondonUK
  3. 3.Imperial College LondonLondonUK

Section editors and affiliations

  • Chris Protzel
    • 1
  • Axel Heidenreich
    • 2
  1. 1.Universitätsklinikum Rostock, Urologische Klinik und PoliklinikRostockGermany
  2. 2.Division of Oncological Urology, Department of UrologyUniversity of KölnKölnGermany

Personalised recommendations